- Home
- RCUS vs TR Comparison
RCUS vs TR Comparison
Compare RCUS & TR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- TR
- Stock Information
- Founded
- RCUS 2015
- TR 1896
- Country
- RCUS United States
- TR United States
- Employees
- RCUS N/A
- TR N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- TR Specialty Foods
- Sector
- RCUS Health Care
- TR Consumer Staples
- Exchange
- RCUS Nasdaq
- TR Nasdaq
- Market Cap
- RCUS 2.4B
- TR 2.8B
- IPO Year
- RCUS 2018
- TR N/A
- Fundamental
- Price
- RCUS $19.94
- TR $39.50
- Analyst Decision
- RCUS Buy
- TR
- Analyst Count
- RCUS 8
- TR 0
- Target Price
- RCUS $27.63
- TR N/A
- AVG Volume (30 Days)
- RCUS 1.8M
- TR 198.6K
- Earning Date
- RCUS 10-28-2025
- TR 10-23-2025
- Dividend Yield
- RCUS N/A
- TR 0.92%
- EPS Growth
- RCUS N/A
- TR 0.79
- EPS
- RCUS N/A
- TR 1.28
- Revenue
- RCUS $240,000,000.00
- TR $729,620,000.00
- Revenue This Year
- RCUS N/A
- TR N/A
- Revenue Next Year
- RCUS N/A
- TR N/A
- P/E Ratio
- RCUS N/A
- TR $30.65
- Revenue Growth
- RCUS N/A
- TR 0.34
- 52 Week Low
- RCUS $6.50
- TR $28.67
- 52 Week High
- RCUS $22.11
- TR $44.27
- Technical
- Relative Strength Index (RSI)
- RCUS 64.34
- TR 53.12
- Support Level
- RCUS $19.33
- TR $38.37
- Resistance Level
- RCUS $20.99
- TR $39.96
- Average True Range (ATR)
- RCUS 1.17
- TR 1.17
- MACD
- RCUS -0.19
- TR 0.40
- Stochastic Oscillator
- RCUS 43.93
- TR 88.21
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.